IDEAYA Biosciences, Inc. IDYA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$113.7M+58.6% | -$274.48M-143% | -$112.96M-87.4% | -$60.27M-21.1% | ||
| $2.7M+13.1% | $2.39M-3.6% | $2.48M+17.8% | $2.1M+21.8% | ||
| $46.12M+32.7% | $34.75M+87.9% | $18.49M+59.0% | $11.63M+41.2% | ||
| $0— | $0+100% | -$193K+78.4% | -$892K— | ||
| —— | —— | —— | —— | ||
| —— | $10.79M+560% | $1.64M-64.2% | $4.57M+8.5% | ||
| $8.03M+30.4% | $6.16M— | —— | $2.12M— | ||
| —— | —— | -$13.75M+70.4% | -$46.48M-97.4% | ||
| $1.89M+30.8% | $1.45M-5.5% | $1.53M+8.3% | $1.41M— | ||
| -$71.1M+71.3% | -$247.58M-115% | -$115.22M-32.2% | -$87.18M-56.3% | ||
| $2.37M-38.6% | $3.86M+62.9% | $2.37M-31.2% | $3.44M+30.2% | ||
| $607.89M-49.0% | $1.19B+99.9% | $595.98M+133% | $255.81M-18.8% | ||
| $680.23M-1.8% | $692.61M+57.4% | $439.89M+94.8% | $225.85M+5,521% | ||
| —— | —— | —— | —— | ||
| $0-100% | $274.69M-2.4% | $281.41M+225% | $86.48M+0.6% | ||
| $29.78M-95.6% | $677.55M+86.8% | $362.72M+273% | $97.17M-33.2% | ||
| —— | -$72.59M-182% | $89.04M+480% | -$23.41M— | ||
| $0-100% | $25K-63.8% | $69K+15.0% | $60K-15.5% | ||
| $9.98M-57.1% | $23.23M+101% | $11.55M+1,562% | $695K+138% | ||
| —— | $10.79M+560% | $1.64M-64.2% | $4.57M+8.5% | ||
| $5.97M— | $0-100% | $13.75M— | —— | ||
| $2.56M+287% | -$1.37M+26.9% | -$1.87M-10.2% | -$1.7M-10.2% | ||
| $8.03M+30.4% | $6.16M— | —— | $2.12M— | ||
| $1.89M+30.8% | $1.45M-5.5% | $1.53M+8.3% | $1.41M— | ||
| $680.23M-1.8% | $692.61M+57.4% | $439.89M+94.8% | $225.85M-7.4% | ||
| —— | —— | —— | —— | ||
| $1.09M-32.6% | $1.62M— | —— | $384K— | ||
| $0— | —— | —— | $0— | ||
| —— | —— | —— | $0— | ||
| —— | —— | —— | —— | ||
| -$73.47M+70.8% | -$251.44M-114% | -$117.59M-29.8% | -$90.62M-55.1% | ||
| -$73.47M+70.8% | -$251.44M-114% | -$117.59M-29.8% | -$90.62M-55.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does IDEAYA Biosciences, Inc. generate?
- IDEAYA Biosciences, Inc. (IDYA) generated -$85.9M in operating cash flow over the trailing twelve months.
- What is IDEAYA Biosciences, Inc.'s free cash flow?
- After $2.0M of capital expenditures, IDEAYA Biosciences, Inc.'s free cash flow was -$87.9M over the trailing twelve months, up 67.2% year over year.
- Where does IDEAYA Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
